FDA authorizes marketing of a new device for use in patients

FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity—or hand, wrist and arm—disability.
Thousands of stroke survivors require rehabilitation each year. Today's authorization offers certain chronic stroke patients undergoing stroke rehabilitation an additional treatment option to help them move their hands and arms again and fills an unmet need for patients who may not have access to home-based stroke rehabilitation technologies."

Related Keywords

United States , Christopherm Loftus , Emily Henderson , Centers For Disease , Radiological Health , Office Of Neurological , Drug Administration , Ipsihand System , Acting Director , Physical Medicine Devices , Disease Control , Breakthrough Device , Muscle , Stroke , Flood , Rain , Hronic , Disability , Education , Medicine , Oxygen , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , மையங்கள் க்கு நோய் , கதிரியக்கவியல் ஆரோக்கியம் , அலுவலகம் ஆஃப் நரம்பியல் , நடிப்பு இயக்குனர் , உடல் மருந்து சாதனங்கள் , நோய் கட்டுப்பாடு , திருப்புமுனை சாதனம் , தசை , மழை ,